Table 5.
Characteristic of convalescents and non-previously SARS-CoV-2 infected participants (n = 50).
| Survey Responses | Non-Previously SARS-CoV-2 Infected (n = 33) | Convalescents (n = 17) | Fisher p-Value Result | |||
|---|---|---|---|---|---|---|
| Number | Percentage (%) | Number | Percentage (%) | |||
| Age | ≥50 | 14 | 42.4 | 5 | 29.4 | 0.5398 |
| <50 | 19 | 57.6 | 12 | 70.6 | ||
| Sex | F | 27 | 81.8 | 14 | 82.4 | 1.000 |
| M | 6 | 18.2 | 3 | 17.6 | ||
| Allergies | Yes | 3 | 9.1 | 0 | 0 | 0.5420 |
| No | 30 | 90.9 | 17 | 100.0 | ||
| Autoimmune diseases | Yes | 5 | 15.2 | 4 | 23.5 | 0.4675 |
| No | 28 | 84.8 | 13 | 76.5 | ||
| Chronic diseases | Yes | 15 | 45.5 | 7 | 41.2 | 1.000 |
| No | 18 | 54.5 | 10 | 58.8 | ||
| Pets at home | Yes | 22 | 66.7 | 10 | 58.8 | 0.7568 |
| No | 11 | 33.3 | 7 | 41.2 | ||
| Vitamin D supplementation | Yes | 22 | 66.7 | 8 | 47.1 | 0.2293 |
| No | 11 | 33.3 | 9 | 52.9 | ||
| Vitamin D concentration | Deficiency | 1 | 3.1 | 1 | 5.9 | 1.000 |
| Insufficient level | 21 | 63.6 | 11 | 64.7 | ||
| Sufficient level | 11 | 33.3 | 5 | 29.4 | ||